Objective Since the declaration of the coronavirus 2019 (COVID-19) outbreak as pandemic,
there are reports on the increased prevalence of physical symptoms observed in the general …

Intravenous thrombolysis is the only approved systemic reperfusion treatment for patients
with acute ischaemic stroke. These European Stroke Organisation (ESO) guidelines provide …

Accumulating evidence points toward a very high prevalence of prolonged neurological
symptoms among coronavirus disease 2019 (COVID-19) survivors. To date, there are no …

The extent of target-organ damage has been positively associated with the magnitude of
blood pressure (BP) variability in essential hypertension. However, the clinical implications of …

INTRODUCTION Transcranial Doppler (TCD) is a physiological ultrasound test with established
safety and efficacy. Although imaging devices may be used to depict intracranial flow …

Background and Purpose— The best time for administering anticoagulation therapy in acute
cardioembolic stroke remains unclear. This prospective cohort study of patients with acute …

Objective Microspheres (μS) reach intracranial occlusions and transmit energy momentum
from an ultrasound wave to residual flow to promote recanalization. We report a randomized …

Importance Thrombosis with thrombocytopenia syndrome (TTS) has been reported after
vaccination with the SARS-CoV-2 vaccines ChAdOx1 nCov-19 (Oxford–AstraZeneca) and Ad26.…

<p>The optimal blood pressure (BP) management in acute ischaemic stroke (AIS) and
acute intracerebral haemorrhage (ICH) remains controversial. These European Stroke …

Objective Emerging data indicate an increased risk of cerebrovascular events with severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and highlight the potential impact of …